Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Thyroid Gland Anaplastic Carcinoma”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)WithdrawnNCT02289144
What this trial is testing

Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer

Who this might be right for
Metastatic Anaplastic Thyroid CancerLocally Advanced Anaplastic, Undifferentiated Thyroid Cancer
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06713057
What this trial is testing

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Who this might be right for
Locally Advanced Thyroid Gland CarcinomaThyroid Cancer
West China Hospital 20
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00005647
What this trial is testing

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00654238
What this trial is testing

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

Who this might be right for
Metastatic Differentiated Thyroid CancerMetastatic Poorly Differentiated Thyroid CancerMetastatic Anaplastic Thyroid Cancer+1 more
University of Pennsylvania 59
Testing effectiveness (Phase 2)UnknownNCT01118065
What this trial is testing

Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Leiden University Medical Center 42
Testing effectiveness (Phase 2)Ended earlyNCT00095693
What this trial is testing

Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerInsular Thyroid CancerRecurrent Thyroid Cancer+4 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT02688608
What this trial is testing

Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer

Who this might be right for
Anaplastic Thyroid Cancer
Saad A Khan 6
Testing effectiveness (Phase 2)Study completedNCT02114658
What this trial is testing

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Who this might be right for
Thyroid Carcinoma
Bayer 18
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT04552769
What this trial is testing

Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Who this might be right for
Thyroid CancerAnaplastic Thyroid CancerUndifferentiated Thyroid Cancer
Stanford University 9
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05119296
What this trial is testing

Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Stanford University 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05453799
What this trial is testing

Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer

Who this might be right for
Locally Advanced Thyroid Gland Anaplastic CarcinomaMetastatic Thyroid Gland Anaplastic CarcinomaMetastatic Thyroid Gland Oncocytic Carcinoma
Northwestern University 54
Testing effectiveness (Phase 2)Study completedNCT02244463
What this trial is testing

A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerThyroid CancerDifferentiated Thyroid Cancer
Dana-Farber Cancer Institute 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT03181100
What this trial is testing

Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaStage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8+4 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Testing effectiveness (Phase 2)Study completedNCT01164176
What this trial is testing

Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Yonsei University 40
Testing effectiveness (Phase 2)Study completedNCT00510640
What this trial is testing

Thyroid Cancer and Sunitinib

Who this might be right for
CancerThyroid Carcinoma
University Hospital, Bordeaux 71
Load More Results